No abstract available.
I tell people I'm unique - almost one of a kind. I am 40 years old and have recently been diagnosed with a rare type of MDS having an unusual deletion 12q cytogenetic abnormality, known MDS 12q (-), or MDS 12q minus. I was diagnosed in February of 2015 at age 38, however my health struggles began several years before that.
Join us for the 2017 March for Marrow NYC: Walk for PNH! Lace up your sneakers and join hundreds of other walkers to raise awareness and funds for research and education for this very rare disease. Register as an individual walker, join an existing team, or start one of your own.
A combination of the BCL-2 inhibitor venetoclax with a hypomethylating agent may produce high overall response rates among older patients with newly diagnosed acute myeloid leukemia (AML), early data showed.